Ibio Inc
NASDAQ:IBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ibio Inc
NASDAQ:IBIO
|
US |
|
G
|
GATX Corp
F:GAX
|
US |
|
K
|
Kontoor Brands Inc
F:3KO
|
US |
|
H
|
Hancock Whitney Corp
F:HH1
|
US |
|
Daiei Kankyo Co Ltd
OTC:DKCLF
|
JP |
|
Saab AB
STO:SAAB B
|
SE |
|
S
|
Six Flags Entertainment Corp
F:6FE
|
US |
|
Lu-Ve SpA
F:V92
|
IT |
|
B
|
Benitec Biopharma Inc
XBER:BJ9
|
US |
|
Gartner Inc
NYSE:IT
|
US |
|
Geberit AG
SIX:GEBN
|
CH |
|
O
|
ONWARD Medical NV
F:63E
|
NL |
Wall St Price Targets
IBIO Price Targets Summary
Ibio Inc
According to Wall Street analysts, the average 1-year price target for
IBIO is 5.64 USD with a low forecast of 4.24 USD and a high forecast of 7.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IBIO's stock price target?
Price Target
5.64
USD
According to Wall Street analysts, the average 1-year price target for
IBIO is 5.64 USD with a low forecast of 4.24 USD and a high forecast of 7.35 USD.
What is the Revenue forecast for Ibio Inc?
Projected CAGR
128%
Over the last 13 years, the compound annual growth rate for Revenue has been -9%. The projected CAGR for the next 8 years is 128%.